EMA — authorised 25 April 2008
- Marketing authorisation holder: Astellas Pharma Europe B.V.
- Status: approved
🇪🇺 Mycamine in European Union
EMA authorised Mycamine on 25 April 2008
Marketing authorisation
Mycamine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in European Union
Frequently asked questions
Is Mycamine approved in European Union?
Yes. EMA authorised it on 25 April 2008.
Who is the marketing authorisation holder for Mycamine in European Union?
Astellas Pharma Europe B.V. holds the EU marketing authorisation.